← Back to Search

Educational Intervention for Colorectal Cancer Screening

N/A

Waitlist Available

Led By Clement K Gwede, PhD, MPH, RN, FAAN

Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Between 45 and 75 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, immediately following intervention, at 3 months and at 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing educational materials about colorectal cancer screenings and the USPSTF recommendations.

Who is the study for?

This trial is for English or Spanish speakers living in the Tampa Bay area (Hillsborough, Pinellas, Polk, or Pasco county), aged between 45 and 75 years old who can consent to participate. It's not open to those outside this age range or location.

What is being tested?

The study provides educational materials about colorectal cancer and screening based on US Preventive Services Task Force recommendations. The goal is to see if these interventions increase awareness and screenings among participants.

What are the potential side effects?

Since this trial involves an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 45 and 75 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, immediately following intervention, at 3 months and at 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, immediately following intervention, at 3 months and at 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately following intervention, at 3 months and at 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Educational Intervention and Referral for Fecal Immunochemical Test (FIT) Kit or ColonoscopyExperimental Treatment1 Intervention

The Community Health Educator (CHE) will provide online, phone or in-person colorectal cancer (CRC) early detection, prevention, and screening education to increase knowledge of CRC and the importance of screening. These sessions will be conducted in small in-person sessions, virtually within a group, virtually via a self-paced/self-directed online learning module, or one-on-one via phone. Additionally, the CHE will provide information regarding FIT kit and colonoscopy screening and the screening process for attendees. The CHE and research assistant will be prepared to provide access to screening resources and services through participants' existing coverage. Those participants who do not have a primary care provider will be provided information on obtaining FIT kits through the mechanisms of the Federally Qualified Health Center (FQHC) and/or a colonoscopy through the cancer center on a case by case basis.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Educational Intervention

2013

N/A

~7120

0 / 1Eligibility criteria met